Please use this identifier to cite or link to this item:
|Title:||Breast Cancer Screening and Diagnosis: A synopsis of the European Breast Guidelines|
|Authors:||SCHÜNEMANN HOLGER; LERDA DONATA; QUINN CECILY; FOLLMANN MARKUS; ALONSO-COELLO PABLO; GIORGI ROSSI PAOLO; LEBEAU ANNETTE; NYSTROM LENNARTH; BROEDERS MIREILLE; IOANNIDOU-MOUZAKA LYDIA; DUFFY STEPHEN; BORISCH BETTINA; FITZPATRICK PATRICIA; HOFVIND SOLVEIG; CASTELLS XAVIER; GIORDANO LIVIA; CANELO-AYBAR CARLOS; WARMAN SUE; MANSEL ROBERT; SARDANELLI FRANCESCO; PARMELLI ELENA; GRÄWINGHOLT AXEL; SAZ PARKINSON ZULEIKA ESTHER|
|Citation:||ANNALS OF INTERNAL MEDICINE vol. 172 no. 1 p. 45-56|
|Publisher:||AMER COLL PHYSICIANS|
|Type:||Articles in periodicals and books|
|Abstract:||Description: In this article we present the European Commission Initiative for Breast Cancer (ECIBC) Screening and Diagnosis guidelines, coordinated by the European Commission's Joint Research Centre, and developed by an international guideline development group. Methods: A guideline panel of 28 multidisciplinary members, including patients, develops questions and corresponding recommendations informed by systematic reviews of the evidence conducted between March 2016 and December 2018. We use Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks to structure the process and minimize the influence of competing interests by enhancing transparency. We focus our questions and recommendations, expressed as strong or conditional, on outcomes that matter to women and provide a rating of the certainty of evidence. Recommendations: This synopsis of the European Breast Guidelines provides recommendations about organized screening programs in women at average risk and 40 to 75 years of age. The recommendations address digital mammography screening and the addition of hand-held ultrasound, automated breast ultrasound or magnetic resonance imaging compared with mammography screening alone. The recommendations also inform decision-making for women at average risk who are recalled for suspicious lesions, women with high breast density and discuss the frequency of screening.|
|JRC Directorate:||Health, Consumers and Reference Materials|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.